Literature DB >> 19807038

[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].

Iu A Meshcheriakova, M A El'darov, A I Migunov, L A Stepanova, I A Repko, O I Kiselev, D P Lomonosov, K G Skriabin.   

Abstract

The epitope presentation system for ectodomain of M2-protein of influenza A virus (M2e) based on Cowpea Mosaic Virus (CPMV) was constructed for expression in plants Vigna unguiculata. CPMV is widely used as a vector for production of immunogenic chimeric virus particles (CVPs) bearing epitopes of different infectious human and animal pathogens. To produce chimeric CPMV virus particles in plants, two binary vectors were constructed bearing modified gene coding for S-coat protein of CPMV with insertions of M2e epitopes of human influenza and bird influenza viruses. Antigenic and immunogenic properties of CVPs obtained were investigated in mice immunization experiments and it was shown that they can induce anti-M2e IgG production and partial protection mice against challenge with low doses of flu virus. However, low infectivity and immunogenicity of CPMV chimeric particles indicate the need for further optimization of plant virus-based systems for M2e-epitopes presentation to use plants as a possible source of flu vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807038

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  8 in total

Review 1.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

2.  High-Yield Expression of M2e Peptide of Avian Influenza Virus H5N1 in Transgenic Duckweed Plants.

Authors:  Aleksey Firsov; Irina Tarasenko; Tatiana Mitiouchkina; Natalya Ismailova; Lyubov Shaloiko; Alexander Vainstein; Sergey Dolgov
Journal:  Mol Biotechnol       Date:  2015-07       Impact factor: 2.695

Review 3.  The use of plants for the production of therapeutic human peptides.

Authors:  Chiara Lico; Luca Santi; Richard M Twyman; Mario Pezzotti; Linda Avesani
Journal:  Plant Cell Rep       Date:  2012-01-05       Impact factor: 4.964

4.  Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein.

Authors:  R Y Kotlyarov; V V Kuprianov; A I Migunov; L A Stepanova; L M Tsybalova; O I Kiselev; N V Ravin; K G Skryabin
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

5.  New viral vector for superproduction of epitopes of vaccine proteins in plants.

Authors:  L G Tyulkina; E V Skurat; O Yu Frolova; T V Komarova; E M Karger; I G Atabekov
Journal:  Acta Naturae       Date:  2011-10       Impact factor: 1.845

Review 6.  Plant-Derived Recombinant Vaccines against Zoonotic Viruses.

Authors:  Gergana Zahmanova; Katerina Takova; Rumyana Valkova; Valentina Toneva; Ivan Minkov; Anton Andonov; Georgi L Lukov
Journal:  Life (Basel)       Date:  2022-01-21

7.  Expression and Immunogenicity of M2e Peptide of Avian Influenza Virus H5N1 Fused to Ricin Toxin B Chain Produced in Duckweed Plants.

Authors:  Aleksey Firsov; Irina Tarasenko; Tatiana Mitiouchkina; Lyubov Shaloiko; Oleg Kozlov; Leonid Vinokurov; Ekaterina Rasskazova; Arkadii Murashev; Alexander Vainstein; Sergey Dolgov
Journal:  Front Chem       Date:  2018-02-13       Impact factor: 5.221

Review 8.  Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents.

Authors:  Stephen J Streatfield; Natasha Kushnir; Vidadi Yusibov
Journal:  Plant Biotechnol J       Date:  2015-10       Impact factor: 9.803

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.